{"title":"Research trends and hotspots of nanomaterials in inflammatory bowel disease: a bibliometric analysis.","authors":"Wuhan Yu, Ning Liu, Ping Gui, Xiufeng Huang, Xiuyong Feng, Linxi Liu, Dandan Yang, Gaoshui Guo, Caiwen Xiong","doi":"10.1080/17435889.2025.2527594","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Inflammatory bowel disease (IBD) is a chronic and nonspecific gastrointestinal disorder, imposing significant physical, emotional, and economic burdens on patients. In recent years, nanomaterials have shown great potential in the management of IBD. This study employs bibliometric analysis to map global research trends and intellectual landscapes in nanomaterials application for IBD.</p><p><strong>Method: </strong>A comprehensive search was conducted on the Web of Science Core Collection database for studies pertaining to nanomaterials and IBD. Bibliometric and visual analysis of the included publications were facilitated by the utilization of Bibliometrix R, VOSviewer and CiteSpace software.</p><p><strong>Result: </strong>A total of 879 studies were included. China, the United States, and Germany are the leading countries in this field. Georgia State University emerged as the most productive institution, while Didier Merlin and Zhang Mingzhen were identified as influential core authors. International Journal of Pharmaceutics was the most productive journal, and Journal of Controlled Release was the most cited journal. Keyword analysis highlighted \"drug delivery,\" \"gut microbiota,\" \"reactive oxygen species\" and \"anti-inflammation\" as dominant research frontiers, with burst keywords such as \"polymeric nanoparticles\" and \"gut microbiotasignaling emerging trends.</p><p><strong>Conclusion: </strong>These findings underscore nanomaterials' transformative potential in IBD management, particularly in targeted therapies and microbiome modulation, while emphasizing the need for interdisciplinary collaboration to address clinical translation challenges.</p>","PeriodicalId":74240,"journal":{"name":"Nanomedicine (London, England)","volume":" ","pages":"1693-1711"},"PeriodicalIF":0.0000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12239822/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nanomedicine (London, England)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/17435889.2025.2527594","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/6 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Inflammatory bowel disease (IBD) is a chronic and nonspecific gastrointestinal disorder, imposing significant physical, emotional, and economic burdens on patients. In recent years, nanomaterials have shown great potential in the management of IBD. This study employs bibliometric analysis to map global research trends and intellectual landscapes in nanomaterials application for IBD.
Method: A comprehensive search was conducted on the Web of Science Core Collection database for studies pertaining to nanomaterials and IBD. Bibliometric and visual analysis of the included publications were facilitated by the utilization of Bibliometrix R, VOSviewer and CiteSpace software.
Result: A total of 879 studies were included. China, the United States, and Germany are the leading countries in this field. Georgia State University emerged as the most productive institution, while Didier Merlin and Zhang Mingzhen were identified as influential core authors. International Journal of Pharmaceutics was the most productive journal, and Journal of Controlled Release was the most cited journal. Keyword analysis highlighted "drug delivery," "gut microbiota," "reactive oxygen species" and "anti-inflammation" as dominant research frontiers, with burst keywords such as "polymeric nanoparticles" and "gut microbiotasignaling emerging trends.
Conclusion: These findings underscore nanomaterials' transformative potential in IBD management, particularly in targeted therapies and microbiome modulation, while emphasizing the need for interdisciplinary collaboration to address clinical translation challenges.
炎症性肠病(IBD)是一种慢性非特异性胃肠道疾病,给患者带来了巨大的身体、情绪和经济负担。近年来,纳米材料在IBD的治疗中显示出巨大的潜力。本研究采用文献计量学分析来绘制纳米材料在IBD中的应用的全球研究趋势和知识格局。方法:在Web of Science Core Collection数据库中全面检索纳米材料与IBD相关的研究。利用Bibliometrix R、VOSviewer和CiteSpace软件对纳入的出版物进行文献计量和可视化分析。结果:共纳入879项研究。中国、美国和德国是这一领域的领先国家。佐治亚州立大学成为最具生产力的机构,而迪迪埃·梅林和张明珍被认为是有影响力的核心作者。被引频次最高的期刊为《International Journal of Pharmaceutics》,被引频次最高的期刊为《Journal of Controlled Release》。关键词分析显示,“药物传递”、“肠道微生物群”、“活性氧”和“抗炎症”是主要的研究前沿,“聚合纳米颗粒”和“肠道微生物分配”等关键词显示了新兴趋势。结论:这些发现强调了纳米材料在IBD治疗中的变革潜力,特别是在靶向治疗和微生物组调节方面,同时强调了跨学科合作解决临床转化挑战的必要性。